LncRNA ARAP1-AS1 targets miR-516b-5p/PDE5A axis to facilitate the progression of thyroid cancer : Anti-Cancer Drugs

Journal Logo

Original article

LncRNA ARAP1-AS1 targets miR-516b-5p/PDE5A axis to facilitate the progression of thyroid cancer

Du, Qiulia,*; Huang, Linb,*; Guo, Weic

Author Information
Anti-Cancer Drugs ():10.1097/CAD.0000000000001438, November 17, 2022. | DOI: 10.1097/CAD.0000000000001438

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid